<DOC>
	<DOC>NCT00138866</DOC>
	<brief_summary>The purpose of this study is to find out if risedronate works for the treatment of osteoporosis for people with spinal cord injury.</brief_summary>
	<brief_title>Risedronate for the Treatment of Osteoporosis for People With Spinal Cord Injury</brief_title>
	<detailed_description />
	<mesh_term>Spinal Cord Injuries</mesh_term>
	<mesh_term>Osteoporosis</mesh_term>
	<mesh_term>Risedronate Sodium</mesh_term>
	<mesh_term>Etidronic Acid</mesh_term>
	<criteria>Traumatic spinal cord injury of greater than 18 months Osteopenia or osteoporosis of the hip Must be able to swallow tablets and sit upright Bilateral heterotopic ossification Bilateral lower extremity metal implants Pregnant or lactating females Paget's disease Osteomalacia Steroid induced bone loss Untreated parathyroid or thyroid disease Symptomatic hypocalcemia or hypophosphatemia Treatment in the last year with calcitonin, fluoride or anabolic steroids Current treatment with prednisone</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>July 2008</verification_date>
	<keyword>Spinal cord injury</keyword>
</DOC>